These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17266900)

  • 1. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
    García-Planella E; Marín L; Domènech E; Bernal I; Mañosa M; Zabana Y; Gassull MA
    Med Clin (Barc); 2007 Jan; 128(2):45-8. PubMed ID: 17266900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
    Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
    Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
    Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
    J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
    Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
    Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.
    Bensoussan M; Jovenin N; Garcia B; Vandromme L; Jolly D; Bouché O; Thiéfin G; Cadiot G
    Gastroenterol Clin Biol; 2006 Jan; 30(1):14-23. PubMed ID: 16514377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
    Serpico MR; Boyle BM; Kemper KJ; Kim SC
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
    Gröchenig HP; Waldhör T; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Miehsler W; Peters PG; Reicht G; Kutschera M; Dejaco C; Vogelsang H; Novacek G;
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1211-1219. PubMed ID: 31498280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
    Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
    Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
    Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The who-when-why triangle of CAM use among Portuguese IBD patients.
    Portela F; Dias CC; Caldeira P; Cravo M; Deus J; Gonçalves R; Lago P; Morna H; Peixe P; Ramos J; Sousa H; Tavares L; Vasconcelos H; Magro F; Ministro P
    Dig Liver Dis; 2017 Apr; 49(4):388-396. PubMed ID: 28117198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
    Opheim R; Hoivik ML; Solberg IC; Moum B;
    J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
    Sirois FM
    Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
    Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia.
    Ong F; Seah Lee W; Lin C; Ng RT; Yee Wong S; Lim SL; Quak SH; Aw M
    Pediatr Neonatol; 2018 Oct; 59(5):494-500. PubMed ID: 29352665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis.
    Weiss A; Friedenberg F
    Drug Alcohol Depend; 2015 Nov; 156():84-89. PubMed ID: 26422462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.